Active-ingredient Dossier

Carbidopa Monohydrate

Active-ingredient Dossier for Carbidopa Monohydrate (decarboxylase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…

Brand: DUODOPA
Brand: KINSON
Brand: LECIGON
Brand: Carbidopa
Therapeutic area: Neurology

What is

Carbidopa Monohydrate Carbidopa monohydrate is a decarboxylase inhibitor.

Australian brands containing

Carbidopa Monohydrate — LECIGON — DUODOPA — SINADOPA — APO-LEVODOPA/CARBIDOPA — KINSON — LECTEVA — SINEMET

Therapeutic areas

Carbidopa monohydrate is registered in neurology, with 10 brands containing this ingredient on the ARTG.

Sponsor landscape

The ingredient is marketed by eight sponsors: Arrotex Pharmaceuticals, Alphapharm, AbbVie, Stada Pharmaceuticals, Teva Pharma and GM Pharma.

PBS and regulatory activity

Three brands with carbidopa monohydrate have PBAC outcomes on record, with the latest outcome dated 1 November 2024. No brands containing this ingredient have AusPARs on record.